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Abstract
Background: Depressive symptoms and chronic disease have adverse effects on patients’ health-related quality of
life (H-RQOL). However, little is known about this effect on H-RQOL when only the two core depressive symptoms
- loss of interest and depressed mood - are considered. The objective of this study is to investigate H-RQOL in the
presence of loss of interest and depressed mood at a general medical outpatient unit.
Methods: We evaluated 553 patients at their first attendance at a general medical outpatient unit of a teaching
hospital. H-RQOL was assessed with the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36).
Depressed mood and loss of interest were assessed by the Primary Care Evaluation of Mental Disorders (PRIME-MD)-
Patient Questionnaire. A physician performed the diagnosis of chronic diseases by clinical judgment and classified
them in 13 possible pre-defined categories. We used multiple linear regression to investigate associations between
each domain of H-RQOL and our two core depression symptoms. The presence of chronic diseases and
demographic variables were included in the models as covariates.
Results: Among the 553 patients, 70.5% were women with a mean age of 41.0 years (range 18-85, SD ± 15.4). Loss
of interest was reported by 54.6%, and depressed mood by 59.7% of the patients. At least one chronic disease was
diagnosed in 59.5% of patients; cardiovascular disease was the most prevalent, affecting 20.6% of our patients. Loss
of interest and depressed mood was significantly associated with decreased scores in all domains of H-RQOL after
adjustment for possible confounders. The presence of any chronic disease was associated with a decrease in the
domain of vitality. The analysis of each individual chronic disease category revealed that no category was
associated with a decrease in more than one domain of H-RQOL.
Conclusion: Loss of interest and depressed mood were associated with significant decreases in H-RQOL. We
recommend these simple tests for screening in general practice.
Background
Depression is an important public health problem asso-
ciated with impairment in quality of life, high levels of
disability, increased medical comorbidity and mortality
rates [1,2]. In primary care, major depression has a high
prevalence ranging from 2.6% to 29.5%, according to
epidemiological studies [3-5].
The Medical Outcomes Study highlighted the evidence
of the adverse effects of depression on patient functional
status and well-being [6,7], and various studies have
reported the relevant impairment of health-related qual-
ity of life (H-RQOL) associated with depression [8-10].
Actually, there is a close association between depres-
sion and various domains of H-RQOL [11]; depression
has been associated with a decrease in experiencing posi-
tive well-being [12], impairment in role functioning [13]
and disabilities in social functioning [14]. In fact, several
studies show a reduction of H-RQOL in patients suffer-
ing from depression as compared with the general popu-
lation [15,16], as well as with patients with chronic
diseases [6,15]. It has also been reported that depressed
patients have more substantial and longer-lasting decre-
ments in multiple domains of functioning and well-being
than patients with chronic diseases [17].
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ease with a reported 12-month prevalence among
patients with chronic disease ranging from 7.9% to 17%
[18]. Major depression in patients with chronic disease
has been associated with increased symptom burden,
which leads to functional impairment, self-care impair-
ment [19], diminished adherence to treatment, under-
mined general perception of health and reduced levels of
energy, social interaction and motivation, consequently
decreasing H-RQOL [20]. Studies have shown that
chronic diseases can be debilitating and affect a patient’s
behavior, mood, work capacity, and vital functions, such
as ambulation, mobility and the capacity to perform daily
activities and eventually H-RQOL [21,22]. These associa-
tions are relevant because chronic disease may potentially
work as a confounding variable in studies focusing on the
negative impact of depression on H-RQOL.
Lately, there has been increased interest in the develop-
ment, validation and clinical utilization of quick screen-
ing and brief scales for depression [23-27]. According to
this approach, previous studies have supported that two
symptoms, depressed mood and anhedonia (loss of inter-
est), may be enough for detecting depression in primary
care [23]. In line with this approach, the aim of our study
was to investigate the association between two core
symptoms of depression (loss of interest and depressed
mood) and H-RQOL in general medical patients taking
into account the presence of comorbid chronic disease.
Methods
Setting
A cross-sectional survey was conducted in a general
internal medicine outpatient unit of a teaching hospital
(Ambulatório Geral e Didático da Clínica Médica do
Hospital das Clínicas, University of Sao Paulo School of
Medicine; AGD - HC-FMUSP) [28,29]. This unit accepts
patients from a catchment area of the city of São Paulo
and patients referred by other services. Candidate
patients are submitted to a screening interview and those
with established severe medical conditions are usually
referred to an appropriated specialized outpatient unit.
During the period from 1998 to 2000, 587 consecutive
patients going through their first attendance in that unit
were assessed.
Study population
We included patients of both genders, aged 18 years or
older that were going through their first attendance in
this hospital’s unit. Patients unable to communicate,
with severe cognitive deficits or unable to participate in
the interview were excluded. We excluded 34 patients
because of incomplete data. The remaining 553 patients
formed the sample of this study.
Patients were evaluated from Monday to Friday during
the morning and afternoon. They were approached and
informed about the scope of the interview. The patients
that agreed to participate had to read and sign the writ-
ten consent.
This study was approved and carried out in accordance
with ethical standards set by the Ethics Committee of the
HC-FMUSP and the Department of Psychiatry, Faculty of
Medicine of the University of Sao Paulo.
Questionnaire
Health-related quality of life was assessed by the Medical
Outcomes Study item-36 Short-Form Health Survey (SF-
36) designed by Ware and Sherboune [30] and validated
for the Brazilian-Portuguese by Ciconelli [31]. This ques-
tionnaire evaluates the state of physical and mental
health individually. The questionnaire consists of 36
items and covers eight domains: physical functioning
(PF), role limitations due to physical problems (RP), bod-
ily pain (BP), general health (GH), vitality (VT), social
functioning (SF), role limitations due to emotional pro-
blems (RE) and mental health (MH). The scores vary
from 0 to 100, and a lower score is associated with a
worse perception of health, loss of function and presence
of pain, and a higher score is associated with a good per-
ception of health, preserved function and no pain.
The SF-36 was designed to be a self-administered instru-
ment, but it can be applied with the assistance of a trained
person. In this study, the patient answered the questions
in the waiting room assisted by a psychologist.
The assessment of loss of interest and depressed mood
were assessed by questions 17 and 18 from the Patient’s
Questionnaire of Prime-Md (QP), which corresponds to
loss of interest in routine activities and depressed mood,
respectively [29].
The assessment of morbidity was performed by clini-
cians who filled a questionnaire with yes/no answers for
t h ep r e s e n c eo fc h r o n i cd i s e a s e s .U s i n gc l i n i c a lj u d g -
ment, clinicians classified the diseases according to 13
predefined categories of disease, including cardiovascu-
lar, infectious, endocrine, neurological, rheumatological,
gastrointestinal, psychiatric, dermatological, orthopedic,
gynaecological, oncological, allergic/immunological or
other chronic diseases.
Statistical methods
The SF-36 scores were calculated according to the estab-
lished scoring algorithms for the Brazilian version of the
SF-36 [31]. The assessment of anhedonia, depressed
mood and chronic diseases were reported as absent or
present. In addition, the sample was analyzed in three
groups including those without chronic disease (n = 225),
those with one chronic disease (n = 260) and those with
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potential gradient effect.
We used multiple linear regression to investigate asso-
ciations between each domain of H-RQOL and our two
core depression symptoms. The presence of chronic dis-
eases and demographic variables were included in the
models as covariates.
The confidence interval was 95% and significance level
was set at p ≤ .05. All statistical analyses were carried
out using SPSS for Windows (version 15.0; SPSS Inc.,
Chicago, IL, USA).
Results
Among the 553 patients, 70.5% were women and the
mean age was 41.0 years (range 18-85, SD ± 15.4). The
assessment of depressive symptoms showed that 54.6%
of the patients presented loss of interest and 59.7% pre-
sented depressed mood. A total of 329 (59.5%) patients
had at least one of the thirteen categories of chronic dis-
eases, with cardiovascular the most common affecting
114 (20.6%) patients. The demographic characteristics of
the sample are shown in Table 1.
The mean values obtained by the whole sample in SF-
36 are listed in Table 2. RP had the lowest score (mean =
32.6) while PF had the highest (mean = 65).
Table 3 shows the univariate analysis with means
values and association of domains of SF-36 with pre-
sence or absence of loss of interest, depressed mood
and chronic diseases. The presence of loss of interest
and depressed mood were significantly associated with
all domains of the SF-36, while the presence of chronic
diseases was associated with a decrease in the domain
vitality. In the investigation of a potential gradient effect
of chronic disease, the group without chronic diseases
showed significantly better scores in the domains PF,
RP, VT and RE. The group with one chronic disease
was significantly associated with lower scores in VT and
the group with two or more chronic disease was signifi-
cantly associated with lower scores in PF, RP and GH.
The results of the multi-variable linear regression are
shown in Table 4, which show the constant for each
domain of H-RQOL for the all sample and the respec-
tive changes for each variable. Loss of interest was asso-
ciated to a reduction of 7.4 points in PF’ss c o r e ,2 6 . 7
points in RP, 8.8 points in BP, 9.3 points in GH, 15.3
points in VT, 18.9 in SF, 17.6) in RE and 11.7 points in
MH. Depressed mood showed association with a
decrease of 6.6 points in PF’s score, 9.8 points in RP, 8.6
points in BP, 13.2 points in GH, 15.1 points in VT, 15.9
points in SF, 19.4 points in RE and 23.4 points in MH.
The presence of a chronic disease was associated with a
decrease of 4.6 points in VT’ss c o r e .T h i sa n a l y s i s
showed that male sex was significantly associated with
higher scores in PF, RP, BP, VT and MH. Patients with
Table 1 Demographics, characteristics and prevalence of
depressive symptoms and chronic disease
Characteristics
Age (M ± SD) 41.0 ± 15.4
Gender
Female, n (%) 390 (70.5)
Male, n (%) 163 (29.5)
Marital status, n (%)
Single 133 (24.1)
Married 281 (50.8)
Divorced 57 (10.3)
Widowed 40 (7.2)
No information 42 (7.6)
Depressive symptoms, n (%)
Loss of interest 302 (54.6)
Depressed mood 330 (59.7)
Chronic Disease, n (%) 329 (59.5)
Cardiovascular 114 (20.6)
Infectious 10 (1.8)
Endocrine 45 (8.1)
Neurological 29 (5.2)
Rheumatological 25 (4.5)
Gastrointestinal 42 (7.5)
Psychiatric 12 (2.1)
Dermatological 20 (3.6)
Orthopedic 19 (3.4)
Gynaecological 16 (2.8)
Oncological 3 (0.3)
Allergic/Immune 26 (4.7)
Other chronic diseases 55 (9.9)
M: mean; SD: standard deviation.
Table 2 Domains of SF-36
Domains of SF-36 M ± SD
PF 65.0 ± 26.5
RP 32.6 ± 40.2
BP 42.5 ± 25.7
GH 57.4 ± 24.5
VT 44.3 ± 23.8
SF 64.9 ± 30.0
RE 43.2 ± 42.8
MH 48.8 ± 24.7
M: mean; SD: standard deviation; SF-36: Short Form Health Survey. PF:
physical functioning; RP: role functioning physical; BP: bodily pain; GH: general
health perceptions; VT: vitality; SF: social functioning; RE: emotional role
functioning; MH: mental health
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patients presented the highest scores in PF, RP and RE.
Discussion
In this study of 553 general practice outpatients, we
found associations between decreased H-RQOL and two
simple screening measures for depression (loss of interest
and depressed mood). Both symptoms were indepen-
dently associated with lower scores on all subscales of
the SF-36. These results are consistent with past reports
of the association between depression and H-RQOL
[8,19,32]. Previous studies have investigated the associa-
tion of H-RQOL with depressive symptoms’ scales or
with the diagnosis of depression. On this point, our study
differs in that we investigated whether only two self-
reported screening symptoms for depression were asso-
ciated with decreased H-RQOL. Because the evaluation
of loss of interest and depressed mood are quick, inex-
pensive and non-invasive and, as shown by our study, are
significantly associated with low H-RQOL, we suggest
they are useful indicators of H-RQOL in general practice.
Our data reinforce previous studies supporting the use
of these two symptoms in screening for major depres-
sive disorder among medical patients. One study with
multiple sclerosis patients found that the presence of
these two symptoms could identify almost all patients
with major depressive disorder, with minimal numbers
of false positive [24]. Another study that used the Beck
Depression Inventory II (BDI-II) to detect major depres-
sive disorder, concluded that one or two questions
regarding sadness and loss of interest serve as simple
and effective screening tools for depression post-acute
myocardial infarction [33].
An intriguing point of our results is the association of
depressed mood and loss of interest with the various
domains of the SF-36. Previous studies have reported
impaired quality of life in patients with depression, espe-
cially when compared to the general population and
patients with other chronic diseases [34], such as diabetes,
arthritis or cardiovascular disease [6,8,17,35]. It should be
noted that the SF-36 includes two domains, the physical
one formed by PF, RP, BP and GH and the mental one
formed by VT, SF, RE and MH. If we apply this reasoning,
our data revealed that the two depressive symptoms affect
both the physical and the mental domains, while chronic
diseases affect almost exclusively the physical domains.
Similar results were described in a study of patients with
differing chronic diseases in Germany that compared the
H-RQOL in patients of general practice with the general
population [22]. Actually, in our study, no specific chronic
disease affected more than one domain of SF-36. A similar
pattern has been reported by a Chinese study, in which
the presence of a chronic disease was associated with
impairment of some but not all domains of H-RQOL [36].
The main difference between these studies and ours is
that we focused only on two depressive symptoms.
Approximately seventy percent of patients visiting the
AGD are female and this proportion is similar to other
studies that assessed the H-RQOL in primary care such
as Fleck et al (2002) [32] (79.5%) and Schwenk et al
(1996) [37] (79.8%). Women’s higher demand for the
health service in our study may have been influenced by
the association found between depressed mood and
female gender (p = 0.02), since there wasn’t any associa-
tion between chronic disease and gender. Alternatively, it
is possible that the increased demand by women for
health services is related to their decreased H-RQOL in
five of the eight domains of the SF-36, PF, RP, BP, VT
and MH, but we cannot establish a causality due to the
cross-sectional nature of our study.
Table 3 Mean values and association of domains of SF-36 with presence or absence of depressive symptoms and
chronic disease
PF RP BP GH VT SF RE MH
All sample (M ± SD) 64.8 ± 26.5 32.6 ± 40.2 42.5 ± 25.7 57.4 ± 24.5 44.3 ± 23.8 64.8 ± 30.1 43.2 ± 42.8 49.7 ± 24.7
Loss of interest (95%
CI)
59.7 ± 25.8
[6.7;15.5]
18.5 ± 31.4
[24.7;37.5]
36.7 ± 23.5
[8.5;17.0]
50.8 ± 23.5
[10.5;18.3]
34.6 ± 19.6
[17.8;25.0]
53.6 ± 29.3
[20.1;29.2]
31.5 ± 39.4
[18.9;32.7]
39.4 ± 21.3
[16.8;24.4]
Without loss of
interest (95% CI)
70.9 ± 26.2
[6.7;15.4]
49.7 ± 43.0
[24.9;37.3]
49.5 ± 26.5
[8.6;16.9]
65.3 ± 23.3
[10.5;18.3]
56.0 ± 23.2
[17.8;25.0]
78.3 ± 25.2
[20.0;29.2]
57.3 ± 42.6
[18.9;32.7]
60.0 ± 23.9
[16.8;24.4]
Depressed mood (95%
CI)
60.5 ± 26.2
[6.2;15.1]
24.2 ± 35.7
[14.0;27.8]
37.0 ± 23.3
[9.2;18.0]
50.5 ± 23.8
[13.1;20.8]
35.6 ± 20.5
[17.8;25.3]
55.4 ± 29.7
[18.5;27.7]
32.4 ± 39.4
[19.8;33.9]
37.3 ± 19.8
[24.9;32.0]
Without depressed
mood (95% CI)
71.2 ± 25.9
[6.2;15.1]
45.1 ± 43.1
[14.3;27.5]
50.7 ± 27.0
[9.4;17.9]
67.5 ± 21.9
[13.0;20.8]
57.2 ± 22.7
[17.9;25.2]
78.6 ± 24.8
[18.4;27.9]
59.3 ± 42.6
[19.9;33.8]
65.7 ± 21.3
[25.0;31.9]
Chronic disease (95%
CI)
61.0 ± 26.6
[5.0;13.8]
28.5 ± 39.4
[3.3;16.9]
42.1 ± 25.9
[-3.2;5.5]
56.0 ± 23.3
[-0.7;7.7]
41.8 ± 23.2
[2.0;10.1]
63.5 ± 30.8
[-1.9;8.1]
40.1 ± 41.9
[0.4;15.1]
48.2 ± 24.8
[-2.7; 5.6]
Without chronic
disease (95% CI)
70.4 ± 25.4
[5.0;13.9]
38.7 ± 40.6
[3.3;16.9]
43.2 ± 25.5
[-3.2;5.5]
59.5 ± 26.0
[-0.6;7.6]
47.9 ± 24.4
[2.0;10.1]
66.6 ± 29.0
[-1.9;8.2]
47.9 ± 43.8
[0.5;15.0]
49.6 ± 24.7
[-2.7; 5.6]
The values shown represent the mean, standard deviation and confidence interval (95% CI). M: mean; SD: standard deviation; SF-36: Short Form Health Survey.
PF: physical functioning; RP: role functioning physical; BP: bodily pain; GH: general health perceptions; VT: vitality; SF: social functioning; RE: emotional role
functioning; MH: mental health.
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more than one of the thirteen chronic diseases. This pre-
valence was relatively low compared with those reported
in the literature. The proportion of multi-morbidity (two
or more medical conditions) in general practice patients
varies in previous studies with Wang et al (2008) [22]
reporting it in 20%, van den Akker et al (1998) [38] in
29.7% and Lam and Lauder (2000) [36] in 41% of the
population under study. However, it is difficult to compare
these studies because of many differences in methodology,
target population, and the number and type of the diseases
under study.
Some limitations of our study should be considered.
The assessment of chronic disease was made by clinical
judgment without validated instruments, and this might
have introduced bias into our results. Furthermore, the
severity of the chronic diseases was not assessed. How-
ever, we performed our analyses using three groups,
those without chronic disease, those with one chronic
disease and those with two or more chronic disease. In
this analysis we found a gradient effect showing that
t h o s ew i t ht w oo rm o r ec h r o n i cd i s e a s ep r e s e n t e dw i t h
lower scores in PF, RP and GH while those with one
chronic disease presented with lower scores only in VT.
Although a gradient effect could be supported, it should
be noted that even for those with two or more chronic
disease the association with lower scores on H-RQOL
w a sn o ta sp e r v a s i v ea si tw a sf o rd e p r e s s e dm o o da n d
Table 4 Multiple linear regressions for the association of domains of SF-36 with depressive symptoms, clinical and
socio-demographic variables
PF RP BP GH VT SF RE MH
Constant 70.9 47.4 49.0 70.7 62.9 85.4 60.6 67.4
Gender (95% CI) +8.8***
[4.4;13.2]
+7.0*
[0.4;13.7]
+10.8***
[6.4;15.2]
- +6.7***
[3.1;10.4]
- - +5.8**
[2.2;9.4]
Categorized age 1 (18-
24 years)
-- - -----
Categorized age 2 (25-
44 years)
-- - -----
Categorized age 3 (45-
64 years)
-- - -----
Categorized age 4 (>65
years)
- - - - - - +9.8 -
Single (95% CI) +14.9***
[10.3;19.5]
+14.7***
[7.6;21.8]
- - - - +12.3**
[4.4;20.1]
-
Loss of interest (95% CI) -7.4** [-11.6;-
3.1]
-26.7***
[-33.2;-20.1]
-8.8***
[-13.1;-4.5]
-9.3***
[-13.3;-5.2]
-15.3***
[-18.8;-11.7]
-18.9***
[-23.7;-14.1]
-17.6***
[-24.8;-10.4]
-11.7***
[-15.2;-8.1]
Depressed mood (95%
CI)
-6.6** [-11.0;-
2.3]
-9.8** [-16.5;-
3.1]
-8.6***
[-13.1;-4.2]
-13.2***
[-17.3;-9.0]
-15.1***
[-18.8;-11.5]
-15.9***
[-20.7;-11.0]
-19.4***
[-26.7;-12.1]
-23.4***
[-27.0;-19.8]
Chronic disease (95%
CI)
- - - - -4.6** [-8.0;-
1.2]
---
Cardiovascular disease
(95% CI)
-12.1***
[-17.0;-7.2]
---- - - -
Endocrine disease (95%
CI)
- - +10.7**
[3.4;18.0]
-----
Rheumatological
disease (95% CI)
- - -12.4*
[-22.1;-2.8]
-----
Psychiatric disease (95%
CI)
- - - -14.9* [-27.9;-
1.9]
----
Dermatological disease
(95% CI)
- - - - - -15.2* [-27.0;-
3.3]
--
Orthopedic disease
(95% CI)
- - - - -11.4* [-20.6;-
2.2]
---
Gynaecological disease
(95% CI)
-17.1**
[-28.9;-5.2]
---- - - -
Oncological disease
(95% CI)
-39.9**
[-66.7;-13.1]
---- - - -
Other chronic diseases
(95% CI)
-11.1**
[-17.7;-4.5]
--- - - -
The values shown represent the regression coefficient and confidence interval (95% CI). One equation was constructed for each domain of SF-36 as the
dependent variable and the depressive symptom, clinical and socio-demographic variable as the independent variable. Each equation was adjusted for variables
found to be associated with the respective domain in the bi-variate analysis. PF: physical functioning; RP: role functioning physical; BP: bodily pain; GH: general
health perceptions; VT: vitality; SF: social functioning; RE: emotional role functioning; MH: mental health.* P < 0.05, ** P < 0.01, *** P < 0.001.
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the impact of the treatment of depression on H-RQOL. It
is also appropriate to mention that this was a cross-sec-
tional study and cannot establish causality between asso-
ciations. Last, while the study suggests that loss of
interest and depressed mood are indicative of low H-
RQL, it should be remembered that these items are not
sufficient to diagnose clinical depression and cannot
replace a comprehensive clinical assessment of mood in
the context of chronic disease.
Conclusion
This study indicates that loss of interest and depressed
mood are associated with decreased H-RQOL. Loss of
interest and/or depressed mood were associated with
lower scores in all eight domains of SF-36, while each
chronic disease affected no more than one domain of H-
RQOL. These findings are relevant because they show
how loss of interest and/or depressed mood might affect
H-RQOL.
This study also suggests that the assessment of loss of
interest and depressed mood would be useful as a screen-
ing for low H-RQOL, since these two questions are quick,
inexpensive and the presence of at least one of these
symptoms has a significant association with reduced
scores in all domains of SF-36.
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